Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial
Conditions: Gastric Cancer; Esophagogastric Junction Cancer Interventions: Drug: Cadonilimab; Drug: Oxaliplatin; Drug: Capecitabine Sponsors: Nanfang Hospital, Southern Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research | Xeloda